statistiche ricercatore

CLEMENTI, MASSIMO

Distribuzione geografica

Continente	#
EU - Europa	1.017
NA - Nord America	255
AS - Asia	19
AF - Africa	1
Totale	1.292

Salva come PNG Salva come JPEG

Nazione	#
IT - Italia	889
US - Stati Uniti d'America	255
IE - Irlanda	76
DE - Germania	18
GB - Regno Unito	17
IN - India	7
AT - Austria	5
CH - Svizzera	5
HK - Hong Kong	5
CN - Cina	4
FI - Finlandia	3
FR - Francia	2
JP - Giappone	1
PL - Polonia	1
SE - Svezia	1
SG - Singapore	1
TR - Turchia	1
ZA - Sudafrica	1
Totale	1.292

Salva come PNG Salva come JPEG

Città	#
Milan	653
Ashburn	100
Dublin	76
Rome	54
Los Angeles	27
Washington	27
Ogden	26
Varese	17
Seattle	14
Como	11
Pune	7
Magnago	5
Vienna	5
Berlin	4
Chiswick	4
Hong Kong	4
London	4
New York	4
West Jordan	4
Frankfurt am Main	2
Hounslow	2
Lugano	2
Paris	2
Pognana Lario	2
Prescot	2
Acton	1
Central	1
Islington	1
Istanbul	1
Johannesburg	1
Kilburn	1
Lappeenranta	1
Lausanne	1
Limbiate	1
Mountain View	1
Southwark	1
Warsaw	1
West Chicago	1
Zurich	1
Totale	1.072

Salva come PNG Salva come JPEG

Nome	#
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs	40
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections	38
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine	37
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes	35
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome	35
Viral respiratory pathogens and lung Injury	34
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools	33
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study	33
Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference	33
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches	33
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2	32
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion?	32
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies	32
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study)	32
Autoimmune hepatitis and occult HCV infection: A prospective single-centre clinical study	32
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice	31
Risks of "blind" automated identification systems in medical microbiology	31
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes	31
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19	31
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?	31
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses	31
Structural and antigenic definition of hepatitis C virus E2 glycoprotein epitopes targeted by monoclonal antibodies	31
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials	30
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death	30
Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes	29
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases	29
Microbiome markers are early predictors of acute GvHD in allogeneic hematopoietic stem cell transplant recipients	29
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens	29
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections	29
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein	28
Diverging effects of human recombinant anti-hepatitis C virus (HCV) antibody fragments derived from a single patient on the infectivity of a vesicular stomatitis Virus/HCV pseudotype	28
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients	28
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia	27
Combined prophylactic and therapeutic use maximizes hydroxychloroquine anti-SARS-CoV-2 effects in vitro	26
A biologically-validated HCV E1E2 heterodimer structural model	26
A case of psoriatic arthritis triggered by SARS-CoV-2 infection	25
Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII)	25
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects	24
Answer to photo quiz: Streptococcus pneumoniae	19
The interferon landscape along the respiratory tract impacts the severity of COVID-19	19
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle	18
Role and potential therapeutic use of antibodies against herpetic infections	18
A human stem cell-derived neurosensory–epithelial circuitry on a chip to model herpes simplex virus reactivation	17
Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity	17
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects	16
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients	16
HCV Proteins and Immunoglobulin Variable Gene (IgV) Subfamilies in HCV-Induced Type II Mixed Cryoglobulinemia: A Concurrent Pathogenetic Role	16
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge	14
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes	13
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection	12
Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab	11
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies	11
Photo quiz: Neurological symptoms in a 74-year-old diabetic woman admitted to the emergency room	11
IFCC interim guidelines on molecular testing of SARS-CoV-2 infection	10
Modulation of epitope-specific anti-hepatitis C virus E2 (Anti-HCV/E2) antibodies by anti-viral treatment	10
Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital	10
IFCC interim guidelines on biochemical/hematological monitoring of COVID-19 patients	10
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy	9
Perspectives for the utilization of neutralizing human monoclonal antibodies as anti-HCV drugs	9
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines	7
Rational dosing strategies of colistin: what about resistance?	5
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site on gp120SITE ON GP120	4
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection	3
Characterization of four major human B-cell epitopes on the surface of HCV E2 glycoprotein by generation of human monoclonal Fab from phage display antibody librariesis	3
Chimeric antigen receptor (CAR)-redirected T cells: is there a place for them in infectious diseases?	2
Nanosphere's Verigene (R) System to detect Multidrug-Resistant Gram-negative Bacterial Outbreak: a prospective study in 60 patients	2
Molecular dissection of the IGM/K antibody repertoire in an HCV-infected patient with cryoglobulinemia	1
Facing the Rising Tide of Multidrug Resistant Gram-Negative Pathogens in Allogeneic HSCT with Nanosphere's Verigene((R)) System	1
Molecular Cloning of a Human Monoclonal Antibody neutralizing a broad range of H1 subtype influenza virus including swine-origin influenza virus (S-OIV)	1
Evaluation of a synergistic interactions of anti-E2/HCV monoclonal antibodies	1
Longitudinal microbiome profile associates with the risk of major transplant-related complications in allogeneic HSCT recipients	1
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin	1
Molecular dissection of the human humoral response against HCV E2 glycoprotein by cloning of the antibody repertoire in phage display combinatorial vectors	1
Rapid Molecular Detection of Pathogens in 516 Consecutive Haematological Patients with Febrile Neutropenia	1
Improving the Diagnostic Algorithm for Sepsis: Adjuvant Role of SeptiFast in 491 Consecutive Hematological Patients	1
Oral and Fecal Microbiota in Lynch Syndrome	1
Microbiological Diagnosis of Sepsis: The Confounding Effects of a “Gold Standard”	1
Multiplex PCR-based assay (SeptiFast) for rapid detection of pathogens in febrile neutropenia: results in 273 consecutive patients	1
Molecular Diagnosis of Scedosporium apiospermum Keratitis	1
Definition of biological activity and quantitation of different families of human anti-HCV/E2 antibodies by generation of human recombinant anti-E2 monoclonal Fab by phage display combinatorial repertoire library	1
Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial	1
Human Monoclonal Antibody able to nneutralize a broad range of H1 and H3 subtype influenza A viruses	1
RAPID MOLECULAR DETECTION OF PATHOGENS IN 1941 BLOOD SAMPLES FROM 516 CONSECUTIVE PATIENTS WITH FEBRILE NEUTROPENIA	1
Totale	1.499

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	10.934
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	10.934

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	232	0	0	0	0	0	0	0	0	123	71	20	18
2023/2024	1.267	163	195	164	256	300	87	7	25	35	35	0	0
Totale													1.499